NDC 55513-206 – Mvasi
Bevacizumab 100 mg/4mL · Injection, Solution · Intravenous
Product NDC55513-206
Product details
- Brand name
- Mvasi
- Generic name
- Bevacizumab-awwb
- Labeler
- Amgen, Inc
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- BLA · BLA761028
- Marketed since
- June 1, 2018
- Listing expires
- December 31, 2027
- Pharmacologic class
- Vascular Endothelial Growth Factor Inhibitor
Active ingredients
- Bevacizumab 100 mg/4mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 55513-206-01 | 1 VIAL in 1 CARTON (55513-206-01) / 4 mL in 1 VIAL | Jun 1, 2018 |
| 55513-206-21 | 1 VIAL in 1 CARTON (55513-206-21) / 4 mL in 1 VIAL | Jun 27, 2025 |
Other Mvasi products
- 55513-207 Bevacizumab 400 mg/16mL · Injection, Solution · Amgen, Inc